H
PFE icon

HoyleCohen’s Pfizer PFE Stock Holding History

HoyleCohen’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$667K Buy
23,850
+2,678
+13% +$73.7K 0.05% 166
2024
Q1 		$588K Sell
21,172
-2,476
-10% -$68.7K 0.04% 188
2023
Q4 		$681K Sell
23,648
-4,372
-16% -$132K 0.06% 172
2023
Q3 		$929K Sell
28,020
-1,945
-6% -$68.8K 0.09% 142
2023
Q2 		$1.1M Buy
29,965
+110
+0.4% +$4.28K 0.1% 137
2023
Q1 		$1.22M Buy
29,855
+2,270
+8% +$98K 0.11% 128
2022
Q4 		$1.41M Sell
27,585
-242
-0.9% -$11.6K 0.14% 121
2022
Q3 		$1.22M Sell
27,827
-1,290
-4% -$62.7K 0.13% 122
2022
Q2 		$1.53M Buy
29,117
+432
+2% +$22K 0.16% 115
2022
Q1 		$1.49M Buy
28,685
+94
+0.3% +$4.88K 0.13% 123
2021
Q4 		$1.69M Sell
28,591
-196
-0.7% -$9.71K 0.14% 119
2021
Q3 		$1.24M Buy
28,787
+639
+2% +$28.3K 0.12% 126
2021
Q2 		$1.1K Buy
28,148
+534
+2% +$20.8K 0.09% 134
2021
Q1 		$1M Buy
27,614
+12,404
+82% +$440K 0.1% 137
2020
Q4 		$560K Buy
15,210
+1,007
+7% +$36.9K 0.06% 151
2020
Q3 		$495K Buy
14,203
+1,335
+10% +$46.8K 0.07% 136
2020
Q2 		$399K Buy
12,868
+139
+1% +$4.72K 0.07% 137
2020
Q1 		$394K Hold
12,729
– – 0.08% 134
2019
Q4 		$473K Buy
12,729
+473
+4% +$16.8K 0.08% 142
2019
Q3 		$418K Buy
12,256
+15
+0.1% +$545 0.07% 148
2019
Q2 		$503K Sell
12,241
-97
-0.8% -$3.85K 0.09% 137
2019
Q1 		$497K Buy
12,338
+1,803
+17% +$72.2K 0.09% 134
2018
Q4 		$436K Sell
10,535
-824
-7% -$34.2K 0.09% 130
2018
Q3 		$475K Buy
11,359
+202
+2% +$7.78K 0.09% 126
2018
Q2 		$384K Sell
11,157
-2,016
-15% -$68.9K 0.08% 133
2018
Q1 		$444K Buy
13,173
+2,005
+18% +$68.9K 0.09% 120
2017
Q4 		$384K Buy
+11,168
New +$381K 0.08% 122

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

HoyleCohen's PFE Position: Q2 2024 in Review

HoyleCohen increased its Pfizer (PFE) stake by 13% in Q2 2024, buying an estimated $73.7K and bringing the position to 23,850 shares worth $667K. The position accounts for 0.05% of the portfolio, ranked #166.

HoyleCohen first reported a position in PFE in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.69M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • HoyleCohen held 23,850 shares of Pfizer worth $667K as of Q2 2024.
  • HoyleCohen bought 2,678 Pfizer shares in Q2 2024, an estimated $73.7K.
  • Pfizer made up 0.05% of HoyleCohen's portfolio in Q2 2024, its #166 holding.
  • HoyleCohen first reported a position in Pfizer in Q4 2017 and has held it in 27 quarters since.
  • HoyleCohen's Pfizer position peaked at $1.69M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.